Literature DB >> 21126187

Properties and applications of single-chain major histocompatibility complex class I molecules.

Eleni Kotsiou1, Joanna Brzostek, Keith G Gould.   

Abstract

Stable major histocompatibility complex (MHC) class I molecules at the cell surface consist of three separate, noncovalently associated components: the class I heavy chain, the β(2)-microglobulin light chain, and a presented peptide. These three components are assembled inside cells via complex pathways involving many other proteins that have been studied extensively. Correct formation of disulfide bonds in the endoplasmic reticulum is central to this process of MHC class I assembly. For a single specific peptide to be presented at the cell surface for possible immune recognition, between hundreds and thousands of peptide-containing precursor polypeptides are required, so the overall process is relatively inefficient. To increase the efficiency of antigen presentation by MHC class I molecules, and for possible therapeutic purposes, single-chain molecules have been developed in which the three, normally separate components have been joined together via flexible linker sequences in a single polypeptide chain. Remarkably, these single-chain MHC class I molecules fold up correctly, as judged by functional recognition by cells of the immune system, and more recently by X-ray crystallographic structural data. This review focuses on the interesting properties and potential of this new type of engineered MHC class I molecule.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21126187      PMCID: PMC3125553          DOI: 10.1089/ars.2010.3694

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  68 in total

1.  Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.

Authors:  Lijin Li; John M Herndon; Steven M Truscott; Ted H Hansen; Timothy P Fleming; Peter Goedegebuure; William E Gillanders
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

2.  Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity.

Authors:  Akash Datwani; Michael J McConnell; Patrick O Kanold; Kristina D Micheva; Brad Busse; Mehrdad Shamloo; Stephen J Smith; Carla J Shatz
Journal:  Neuron       Date:  2009-11-25       Impact factor: 17.173

3.  A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.

Authors:  Baomei Wang; Tina M Primeau; Nancy Myers; Henry W Rohrs; Michael L Gross; Lonnie Lybarger; Ted H Hansen; Janet M Connolly
Journal:  Science       Date:  2009-11-06       Impact factor: 47.728

4.  A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.

Authors:  Michael J Palmowski; Mathew Parker; Kaushik Choudhuri; Christopher Chiu; Margaret F C Callan; P Anton van der Merwe; Vincenzo Cerundolo; Keith G Gould
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

5.  Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates.

Authors:  Brian D Rudd; James D Brien; Miles P Davenport; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

Review 6.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

7.  Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies.

Authors:  Yael Michaeli; Galit Denkberg; Keren Sinik; Liz Lantzy; Chiang Chih-Sheng; Celine Beauverd; Tamar Ziv; Pedro Romero; Yoram Reiter
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

8.  Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association.

Authors:  Helen Fussell; Darren Nesbeth; Izabela Lenart; Elaine C Campbell; Sarah Lynch; Susana Santos; Keith Gould; Simon J Powis; Antony N Antoniou
Journal:  Arthritis Rheum       Date:  2008-11

9.  Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.

Authors:  Takashi Ohashi; Mika Nagai; Hiroyuki Okada; Ryo Takayanagi; Hisatoshi Shida
Journal:  Retrovirology       Date:  2008-10-08       Impact factor: 4.602

10.  Peptide-major histocompatibility complex dimensions control proximal kinase-phosphatase balance during T cell activation.

Authors:  Kaushik Choudhuri; Mathew Parker; Anita Milicic; David K Cole; Michael K Shaw; Andrew K Sewell; Guillaume Stewart-Jones; Tao Dong; Keith G Gould; P Anton van der Merwe
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

View more
  4 in total

1.  Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.

Authors:  Masanori Matsui; Masaaki Kawano; Sho Matsushita; Toshitaka Akatsuka
Journal:  Mol Ther Methods Clin Dev       Date:  2014-07-02       Impact factor: 6.698

2.  Non-Stimulatory pMHC Enhance CD8 T Cell Effector Functions by Recruiting Coreceptor-Bound Lck.

Authors:  Xiang Zhao; Liang-Zhe Wu; Esther K Y Ng; Kerisa W S Leow; Qianru Wei; Nicholas R J Gascoigne; Joanna Brzostek
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

3.  Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules.

Authors:  Izabela Lenart; Linh-Huyen Truong; Dinh Dung Nguyen; Olga Rasiukienė; Edward Tsao; Jonathan Armstrong; Pankaj Kumar; Kirsty McHugh; Branca I Pereira; Balraj S Maan; Malgorzata A Garstka; Paul Bowness; Neil Blake; Simon J Powis; Keith Gould; Darren Nesbeth; Antony N Antoniou
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

4.  Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.

Authors:  Xiang Zhao; Shvetha Sankaran; Jiawei Yap; Chien Tei Too; Zi Zong Ho; Garry Dolton; Mateusz Legut; Ee Chee Ren; Andrew K Sewell; Antonio Bertoletti; Paul A MacAry; Joanna Brzostek; Nicholas R J Gascoigne
Journal:  Nat Commun       Date:  2018-07-13       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.